Abstract
The Fic (filamentation induced by cyclic AMP) domain is a widely distributed motif with a conserved sequence of HPFx[D/E]GN[G/K]R, some of which regulate cellular activity by catalyzing the transfer of the AMP moiety from ATP to protein substrates. Some Fic proteins, including Fic-1 from the soil bacterium Pseudomonas fluorescens strain 2P24, have been shown to inhibit bacterial DNA replication by AMPylating the subunit B of DNA gyrase (GyrB), but the biochemical activity and cellular target of most Fic proteins remain unknown. Here, we report that Fic-2, which is another Fic protein from strain 2P24 and Fic-1 AMPylate the topoisomerase IV ParE at Tyr109. We also examined Fic proteins from several phylogenetically diverse bacteria and found that those from Yersinia pseudotuberculosis and Staphylococcus aureus AMPylate ParE and GrlB, the counterpart of ParE in Gram-positive bacteria, respectively. Modification by Fic-1 of P. fluorescens and FicY of Y. pseudotuberculosis inhibits the relaxation activity of topoisomerase IV. Consistent with the inhibition of ParE activity, ectopic expression of these Fic proteins causes cell filamentation akin to the canonical par phenotype in which nucleoids are assembled in the center of elongated cells, a process accompanied by the induction of the SOS response. Our results establish that Fic proteins from diverse bacterial species regulate chromosome division and cell separation in bacteria by targeting ParE.
Introduction
Fic proteins are a family of proteins that harbor the conserved Fic motif (HPFx[D/E]GN[G/K]R). Members of this protein family are found in both prokaryotes and eukaryotes (Kinch et al., 2009; Worby et al., 2009). The majority of characterized Fic proteins catalyze a reversible adenylylation/AMPylation reaction in which the adenosine monophosphate (AMP) moiety is transferred from adenosine triphosphate (ATP) to specific protein targets. This covalent modification induced by Fic proteins typically requires an invariant histidine residue within the core Fic motif (Worby et al., 2009; Yarbrough et al., 2009). In addition to AMPylation, Fic proteins are capable of catalyzing such modifications as UMPylation (Feng et al., 2012), phosphorylcholination (Mukherjee et al., 2011; Tan et al., 2011) and phosphorylation (Castro-Roa et al., 2013; Cruz et al., 2014). The activity of Fic proteins is strictly regulated by a variety of mechanisms, including auto-AMPylation, oligomerization, inter- or intra-molecular inhibition, inhibitory domain-independent inhibition and de-modification by specific enzymes (Tan and Luo, 2011; Tan et al., 2011; Engel et al., 2012; Dedic et al., 2016; Lu et al., 2016; Stanger et al., 2016; Sprenger et al., 2017). In particular, HYPE (also known as FICD) from humans is a bi-functional enzyme that possesses both AMPylation and de-AMPylation activities to regulate the activity of the chaperone BiP in the endoplasmic reticulum (Grammel et al., 2011; Rahman et al., 2012; Ham et al., 2014; Sanyal et al., 2015; Casey et al., 2017; Preissler et al., 2017; Moehlman et al., 2018).
The cellular targets of Fic proteins are highly diverse, ranging from proteins involved in immunity, which are attacked by Fic effectors from pathogens of mammalian or plant hosts (Worby et al., 2009; Yarbrough et al., 2009) to proteins involved in protein folding such as the chaperone BiP (Sanyal et al., 2015), core histones (H2 and H3), translation elongation factors (Castro-Roa et al., 2013; Cruz et al., 2014), and bacterial type IIA family of topoisomerases (GyrB and ParE) (Harms et al., 2015; Lu et al., 2016; Stanger et al., 2016). In most cases, the post-translational modification induced by Fic proteins leads to inhibition of target protein activity (Truttmann and Ploegh, 2017).
The Fic protein VbhT from the bacterial pathogen Bartonella schoenbuchii strain R1 modifies both GyrB and ParE by AMPylation (Harms et al., 2015; Siamer and Dehio, 2015). Strain 2P24 of the soil bacterium Pseudomonas fluorescens used for biological control against plant diseases (Wei and Zhang, 2006; Wu et al., 2010; Zhang et al., 2014) harbors multiple Fic proteins. Among them, Fic-1 interferes with DNA replication by AMPylating the conserved Tyr111 of P. fluorescens GyrB (PfGyrB), leading to inhibition of its ATPase activity (Lu et al., 2016).
In an effort to identify additional targets of Fic-1, we found that it recognizes and AMPylates ParE of P. fluorescens (PfParE) at Tyr109, a residue that is corresponding to Tyr105 of ParE from Escherichia coli. We also found that Fic-2, another Fic protein from P. fluorescens modifies ParE. We extended our study by examining nine Fic proteins from several phylogenetically diverse bacterial species for their ability to modify GyrB or ParE and found that Fic-2 of P. fluorescens, FicY of Yersinia pseudotuberculosis and Sa1560 of Staphylococcus aureus function to modify ParE or GrlB, the counterpart of ParE in Gram-positive bacteria by AMPylation. We further showed that the modification inhibits ParE’s ability to relax supercoiled DNA. Finally, heterologous expression of Fic-2E56G which is a constitutively active mutant of Fic-2, FicY, PA1366, and Fic-1 in E. coli caused cell filamentation and the induction of the SOS response. Our results suggest that the ParE subunit of Topo IV appears to be a common target for Fic proteins in a diverse set of bacteria, which play a role in the regulation of DNA replication under certain conditions.
Materials and Methods
Bacterial Strains, Plasmids, and Media
The bacterial strains and plasmids used in this study are listed in Supplementary Table S1. All oligonucleotide primers are listed in Supplementary Table S2. E. coli strains DH5α and BL21(DE3) were grown in Luria-Bertani (LB) medium at 37°C. P. fluorescens strain 2P24, Y. pseudotuberculosis strain YPIII and E. coli strain BTH101 were grown at 30°C in LB medium. For induction of proteins of interest, overnight cultures grown in LB supplemented with 0.2% glucose and the appropriate concentration of antibiotics were washed with distilled water once and diluted five-fold using Agrobacterium mannitol (ABM) minimal medium with 0.5% of glycerol as the carbon source and 0.2% of arabinose as the inducer. When needed, media were supplemented with antibiotics at the following concentrations: ampicillin (100 μg/ml), kanamycin (50 μg/ml), gentamicin (10 μg/ml), chloramphenicol (20 μg/ml), and tetracycline (5 μg/ml).
Bacterial Two-Hybrid
The protocol used for bacteria two-hybrid assays was performed as described previously (Lu et al., 2016). The genes of interest were cloned onto pKT25 or pUT18C, and the interaction between Fic-1 and ParE was assayed on LB plates supplemented with X-gal. The strength of the interactions was quantified by measuring the activity of galactosidase (Miller, 1972). Briefly, the OD600 of cultures grown in LB broth with the appropriate concentration of kanamycin and ampicillin for 24 h at 30°C was measured. 0.1 ml of samples were added to 0.9 ml of Z-buffer (60 mM Na2HPO4⋅12H2O, 40 mM NaH2PO4⋅2H2O, 1 mM MgSO4⋅7H2O, 10 mM KCl and 50 mM β-mercaptoethanol, pH 7.0), 40 μl of chloroform and 20 μl of 0.1% SDS were also added. Mixtures were incubated at 30°C for 15 min, then 0.2 ml of 4 mg/L ortho-nitrophenyl-β-galactoside (ONPG) was added to start the reactions, which were then stopped by adding 0.2 ml of Na2CO3 until the color of the solutions became light yellow. If the color change was not detected, all reactions were stopped 30 min after the addition of ONPG. After centrifugation at 12,000 rpm for 5 min, OD420 of the supernatants was measured by a spectrophotometer. Each sample set was measured in triplicate. β-galactosidase activity was calculated by the equation: 1U = (OD420 × 1000)/(OD600 × Volume × Time), in which the unit of volume is ml and time is min.
Plasmids and Strains Construction
Putative Fic proteins from P. fluorescens 2P24, P. aeruginosa PAO1, Y. pseudotuberculosis YPIII, S. aureus USA300 and Streptococcus pneumoniae D39 each was cloned into the expression vector pETSUMO as BamHI/SalI fragments. The fic gene from Mycobacterium tuberculosis CDC1551 was inserted into pET22b(+) or pIADL16 as a NdeI/SalI fragment to produce His6-tagged or His6-MBP (Maltose binding protein)-tagged proteins, respectively.
The gene for the DNA gyrase subunit B (gyrB) and its counterpart, topoisomerase IV subunit B (parE or grlB) for relevant bacteria were inserted into pETSUMO to produce His6-tagged proteins. For M. tuberculosis CDC1551, the only gyrB was cloned as it does not have a parE gene.
For expression of Fic-2 in P. fluorescens 2P24, pCL008 was used as described previously (Lu et al., 2016). To test its effects on cell morphology, the fic gene from Y. pseudotuberculosis YPIII (Wang et al., 2015) was inserted into pBAD22, its expression was induced by 0.2% arabinose. The integrity of each gene was verified by double-strand sequencing analysis.
Site-Directed Mutagenesis
We used the QuikChange® mutagenesis kit to introduce mutations into specific sites of genes of interest by the high-fidelity DNA polymerase Pfu Ultra II (Agilent Technologies). The primers were designed by the QuikChange® Primer Design Program (Agilent Technologies).
Expression and Purification of Proteins
Unless otherwise stated, E. coli strain BL21(DE3) was used to express proteins of interest. The bacterial strain was inoculated in 25-ml of L. broth with appropriate antibiotics in a 250-ml flask shaking at 225 rpm for 6 h. Each culture was sub-cultured in 500 ml of L. broth in a 2-L flask until the absorbance at 600 nm reached between 0.6 and 0.8. Isopropyl thio-D-galactopyranoside (IPTG) was then added to a final concentration of 250 μM, and the induction was allowed to proceed for 16 h at 18°C. The cells were harvested by centrifugation at 6,000 rpm for 10 min at 4°C and resuspended in 30 ml cold PBS buffer containing 20 mM imidazole and protease inhibitors benzamidine and phenylmethanesulfonyl fluoride (PMSF) at final concentrations of 5 and 1 μM, respectively. Mixtures were then lysed by sonication. After spinning down the pellets by centrifugation at 12,000 rpm for 15 min twice at 4°C, supernatants were mixed with 2 ml Ni-NTA beads in 50-ml Falcon tubes, Triton X-100 was added to a final concentration of 0.5% and the binding was allowed to proceed at 2 h at 4°C while rotating. The Ni2+-NTA beads were loaded into a 30-ml column and beads were washed with 60 ml PBS buffer containing 20 mM imidazole by gravity flow. The bound proteins were eluted with PBS buffer containing 250 mM imidazole. The purity of the protein (normally 2–5 μl) was assessed by SDS-PAGE and Coomassie brilliant blue before dialyzing against 1 L PBS containing 20% (v/v) glycerol and 1 mM β-mercaptoethanol at 4°C for 16 h. Protein concentration was determined by the Bradford assay (Bio-Rad). When needed, the SUMO protease Ulp1 was used to cleave the His6-SUMO tag from fusion proteins at 30°C for 3 h.
In vitro AMPylation Assay
The AMPylation assay was performed as described with minor modifications (Tan and Luo, 2011; Tan et al., 2011; Lu et al., 2016). Briefly, 3 μg of purified Fic was incubated with 10 μg His6-SUMO-GyrB or His6-SUMO-ParE for 45 min at 35°C in 20 μl of reaction buffer containing 25 mM Tris–HCl, pH 7.5, 50 mM NaCl, 3 mM MgCl2, 0.5 mM EDTA, and 32P-α-ATP (5 μCi) (Perkin Elmer). When needed, 1.5 μg Fic-1-His6 was incubated with purified GyrB or ParE proteins. After reactions were stopped by the addition of 5 μl of 5× SDS sample buffer, samples were boiled for 10 min at 100°C and separated on 4–20% gradient SDS-PAGE gels (Bio-Rad) at 120 volts for 80 min. Gels were stained with Coomassie brilliant blue and destained with a solution containing 45% methanol, 10% acetic acid and 45% ddH2O. Detection of 32P-α-AMP-labeled molecules was done by autoradiography using dried PAGE gels and Biomax MS films (Kodak).
Auto-AMPylation by Fic proteins detected by fluorescence were conducted using the following protocol using the fluorescence ATP analog N6-(6-Amino)-hexyl-ATP-5-FAM (ATP-FAM, JBS-NU-805-5FM, Jena Bioscience). Briefly, ten micrograms of Fic protein were incubated with 5 μM ATP-FAM in 20 μl AMPylation buffer containing 25 mM Tris–HCl, pH 7.5, 50 mM NaCl, 3 mM MgCl2 and 0.5 mM EDTA for 1 h at 35°C. The reactions were terminated with the SDS sample buffer and were boiled for 5 min. Proteins were separated on 12% SDS-PAGE gels and fluorescence signals (λex = 488 nm, λem = 526 nm) were measured by using the green channel of an iBright FL1500 Imaging System (Thermo Fisher Scientific).
To test the inhibition of FicY by AntY, a 120 μl master reaction containing 30 μg His6-SUMO-FicY was used to set up sub-reactions with different amounts of His6-SUMO-AntY. Reactions were incubated at room temperature for 30 min, followed by the addition of 10 μg His6-SUMO-ParE into each reaction. A reaction not receiving His6-SUMO-AntY was used as a control. After incubation at 35°C for 30 min, the reactions were terminated with the SDS sample buffer. Reaction products were separated on 4–20% prepared SDS-PAGE, and signals were detected by autoradiography with Biomax MS films (Kodak).
Negative Supercoiling and Relaxation of Plasmid DNA in vitro
Supercoiled plasmid DNA was prepared by isolating pHSG399 from E. coli strain DH5α. Relaxed plasmid DNA was produced by treating supercoiled pHSG399 with topoisomerase I (NEB) in 1× CutSmart buffer (50 mM KAc, 20 mM Tris–Ac, 10 mM Mg(Ac)2, and 100 μg/ml BSA, pH 7.9; NEB).
The negative supercoiling assay was performed in a reaction mixture containing 1× DNA gyrase reaction buffer (35 mM Tris–HCl, pH 7.5 at 25°C, 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.75 mM ATP, 5 mM spermidine, 0.1 mg/ml BSA, 6.5% Glycerol; NEB), 0.3 μg of relaxed pHSG399 DNA, and appropriate amounts of DNA gyrase. The optimal concentration of gyrase was determined by adding a diluent. For dose-dependent inhibition of DNA gyrase supercoiling activity by Fic proteins, increasing amounts of Fic proteins were pre-incubated with DNA gyrase in a reaction mixture without relaxed DNA at 30°C for 1 h. The reactions were initiated by adding 0.3 μg relaxed pHSG399, incubated for 1 h, and stopped using 20 mM EDTA.
Relaxation of negative supercoils was assayed in a reaction mixture (20 μl) containing 35 mM Tris–HCl, pH 7.5 at 25°C, 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.75 mM ATP (unless indicated otherwise), 5 mM spermidine, 0.1 mg/ml BSA, 6.5% Glycerol, 0.3 μg of negatively supercoiled pHSG399 DNA, and indicated amounts of Topo IV. The effect of Fic on the relaxation of negative supercoiled DNA by DNA gyrase was determined in reactions without ATP. The optimal concentration of Topo IV from each organism was determined by three-fold dilution of the proteins. When needed, a set amount of Fic proteins was pre-incubated with Topo IV in reaction buffer without DNA at 30°C for 1 h. The reaction was started by adding 0.3 μg negatively supercoiled pHSG399 DNA, continued for 1 h at 30°C, and terminated by EDTA (final concentration of 20 mM). The reactions were analyzed by electrophoresis in 1.2% agarose gels at 2.5 V/cm for 12 h in 50 mM Tris–HCl, pH 8.0 at 25°C, 40 mM NaOAc, and 1 mM EDTA running buffer. DNA agarose gels were stained with 1 μg/ml ethidium bromide for 10 min prior to image acquisition by an iBright FL1500 Imaging System.
Microscopy
After induction of Fic, ParE and their mutant versions, bacteria cells of E. coli, P. fluorescens or Y. pseudotuberculosis were washed with PBS and fixed with 4% paraformaldehyde following a described protocol (Lu et al., 2016).
Antibodies and Immunoblotting
SUMO, FicY, and ParE-specific antibodies were raised and purified as described earlier (Lu et al., 2016). The antibody was used at 1:10,000 for immunoblotting. Antibodies against ICDH (Lu et al., 2016), RecA (Santa Cruz Biotechnology), and LexA (Abcam) were used at 1:10,000, 1:3000 and 1:5000, respectively.
For immunoblotting, samples were separated by 8–15% SDS-PAGE, proteins were transferred onto nitrocellulose membranes and the membranes were blocked with 5% nonfat milk in PBS with 0.2% Tween 20 (PBST) for 1 h, the membranes were washed three times with PBST buffer and incubated with the primary antibody for 2 h. After washing, membranes were incubated with a fluorescence-labeled secondary antibody labeled with IRDye 700 or IRDye 800 (Li-COR Biosciences), and the signals were detected with the LI-COR Odyssey Imaging System (Li-COR Biosciences).
Statistical Analyses
Images of blots were converted into a JPEG file format, then changed the picture mode to “Grayscale”. The intensity of target bands was relatively quantified by using NIH ImageJ (version 1.52q) densitometric software. The same frame was used for all of the protein bands [including LexA, RecA and ICDH (isocitrate dehydrogenase)] and their backgrounds. The pixel density for all data was inverted (255-X, where X is the value recorded by Image J). For the protein bands and loading controls, express the net value by deducting the inverted background from the inverted band value. The final relative quantification values are the ratio between net band of the samples and that of the loading control. The Student’s t test was used to compare the mean levels between the two groups. A p-value less than 0.05 was considered statistically significant.
Results
Fic-1 AMPylates Topo IV Subunit B (PfParE) at Tyr109
We previously showed that Fic-1 (locus tag: C0J56_10235) of P. fluorescens strain 2P24 inhibits DNA replication by AMPylating GyrB (Lu et al., 2016). Since ParE is a paralog of GyrB, we examined its interactions with Fic-1. Binding between these two proteins was evident in a bacterial two-hybrid assay as significant galactosidase activity was observed in the E. coli strain BTH101 (Karimova et al., 1998) co-expressing Fic-1 and PfParE fused to the T18 and T25 fragment of adenylate cyclase (CyaA), respectively (Figure 1A). Furthermore, PfParE can be co-purified with Fic-1 or Fic-1H135A (mutation of His135 to Ala in the conserved Fic motif) in the pulldown assay (Figure 1B). Thus, Fic-1 detectably interacts with ParE, and its inactive mutant Fic-1H135A retains this binding activity.
FIGURE 1
The interaction between ParE and Fic-1 prompted us to determine whether Fic-1 could modify the DNA topoisomerase by AMPylation. We thus incubated Fic-1 and ParE together with 32P-α-ATP and examined potential modification by autoradiograph. Our results revealed that ParE from both P. fluorescens (PfParE) and E. coli (EcParE) can be robustly AMPylated by Fic-1 and such modification completely depended upon the histidine residue essential for its enzymatic activity (Figures 2A,B).
FIGURE 2
Residue Tyr109 in PfParE is conserved in ParE across prokaryotes and is functionally equivalent to Tyr111 in PfGyrB, which is the site modified by Fic-1 (Supplementary Figure S1A) (Lu et al., 2016). We therefore speculated that Tyr109 is the likely AMPylation site on PfParE. Indeed, a Y109A mutation in this protein rendered it no longer modifiable by Fic-1 (Figure 2A). Mutation of the corresponding residue Tyr105 (Supplementary Figure S1A) also abolished the ability of EcParE to be modified by Fic-1 (Figure 2B). In these experiments, a 32P-labeled protein with a molecular weight higher than that of ParE was detected (Figure 2). This band likely is endogenous E. coli GyrB co-purified with Fic-1 due to the high affinity between these two proteins (Lu et al., 2016). In reactions containing the EcParEY105A mutant, the signals were still detectable (Figure 2B), which may result from additional modification sites on EcParE.
Fic Proteins From Diverse Bacteria AMPylate ParE in vitro
Fic proteins are present in a large cohort of bacteria, both Gram-positive and Gram-negative, but their cellular targets in most of these microorganisms remain unknown (Veyron et al., 2018). The finding that Fic-1 modified GyrB and ParE prompted us to examine whether these proteins are modified by Fic proteins in several taxonomically diverse bacteria, including the E. coli strain K12 (Blattner et al., 1997), P. aeruginosa strain PAO1 (Stover et al., 2000), Mycobacterium tuberculosis strain CDC1551 (Liu et al., 2016), Y. pseudotuberculosis strain YPIII (Johnson et al., 2015), S. aureus strain USA300 (Diep et al., 2006), and S. pneumoniae strain D39 (Lanie et al., 2007) (Supplementary Figures S1B,C). Some Fic proteins from these species, including EcFic (locus tag: b3361) from E. coli strain MG1655, PA1366 from P. aeruginosa strain PAO1, MT3743 from M. tuberculosis strain CDC1551 and FicY (locus tag: YPK_0608) from Y. pseudotuberculosis YPIII, belong to class I Fic. The first three Fic proteins listed above appear to be regulated by a predicted intermolecular inhibitor protein encoded upstream of these Fic genes, whereas the predicted inhibitory motif for FicY is encoded by a downstream, convergent open reading frame that we termed antY (Supplementary Figures S1D,E,S2). The predicted Fic-2 (locus tag: C0J56_09765) and Fic-3 (locus tag: C0J56_23350) from P. fluorescens strain 2P24, PA0574 (locus tag: PA0574) from P. aeruginosa strain PAO1 and Sa1560 (locus tag: SAUSA300_1560) from S. aureus strain USA300 belong to class II, and Sp0496 (locus tag: SPD_0496) from S. pneumoniae strain D39 is a class III Fic protein (Supplementary Figure S2).
To examine the potential activity of these Fic proteins against GyrB and ParE, we first substituted the glutamate residue within the predicted Fic inhibitory domain (Engel et al., 2012) to create constitutively active mutants Fic-2E56G, Fic-3E62G, PA0574E63G, Sa1560E107G, and Sp0496E243G. Each Fic protein and its presumably constitutively active mutant were purified from E. coli by His6 affinity purification. Each of these proteins was incubated in reactions containing 32P-α-ATP and their cognate GyrB or ParE. Modification of the potential targets was detected by autoradiograph. In reactions containing GyrB, similar to earlier results, GyrB was robustly AMPylated by Fic-1 (Figure 3A, top panel) (Lu et al., 2016). No signal of AMPylated GyrB was detected in reactions containing Fic proteins from other bacterial species even when the exposure time was extended to 13 h. In addition, a protein of approximately 70 kDa was modified in the reaction containing GyrB and FicY, which may result from an additional target likely co-purified with FicY (Figure 3A, middle panel).
FIGURE 3
When ParE was used as the substrate, strong modification signals were detected in reactions containing FicY from Y. pseudotuberculosis (Figure 3B top panel). In reactions containing Fic-2E56G and ParE from P. fluorescens, weak modification signals were detected after exposure for over 13 h. Weak modification of SaGrlB which is the ParE equivalent in S. aureus was reproducibly detected when incubated with Sa1560 or its constitutively active mutant Sa1560E107G. In contrast, Fic proteins from neither P. aeruginosa nor S. pneumoniae detectably AMPylated their ParE counterparts (Figure 3B middle panel). These results indicate that, compared to GyrB, more Fic proteins (Fic-1, Fic-2E56G, FicY, and Sa1560E107G) AMPylate ParE or its counterpart GrlB in Gram-positive bacteria, suggesting that topoisomerase IV is the preferred target for the examined Fic proteins.
Fic Proteins AMPylate ParE on a Tyrosine Residue Important for ATP Binding
Given the high degree similarity between GyrB and ParE, we predicted that FicY modifies YpParE at Tyr106, a site that is equivalent to Tyr111 modified by Fic-1 in GyrB from P. fluorescens. To test this hypothesis, we created the YpParEY106A mutant. In reactions containing YpParE and 32P-a-ATP, robust modification was detected in reactions containing FicY, but not the FicYH141A mutant in which the histidine residue within the core Fic motif was mutated into alanine. No modification signal was detected when YpParEY106A was used (Figure 4A), validating that Tyr106 of YpParE is the modification site. Interestingly, when EcParEY105A was used in the reaction, weak signals were still detected, suggesting that in addition to Tyr106, FicY modifies additional site(s) in EcParE at lower efficiencies (Figure 4B). Thus, Tyr106 is the major YpParE site modified by FicY.
FIGURE 4
When Fic-2E56G was incubated with PfParE or EcParE in AMPylation reactions; weaker signals were detected in reactions containing Fic-2E56G and PfParEY109A or Fic-2E56G and EcParEY105A. No signal was detected when Fic-2H179A was used in the reactions (Figures 4C,D). These results suggest that more than one amino acid is AMPylated in PfParE by Fic-2E56G.
In reactions containing Sa1560 and SaGrlB or SaGrlBY109A, Sa1560E107G and SaGrlB or SaGrlBY109A, weak signals of AMPylated SaGrlB and auto-modification signals were seen for Sa1560 from S. aureus strain USA300, which appeared to occur independently of its inhibitory domain (Supplementary Figure S3).
AntY Inhibits the Activity of FicY
Sequence analysis revealed that an open reading frame downstream of ficY encodes a small protein that contains the -S22TAIET27- motif found in canonical Fic inhibitor elements (S/T)xxxE(G/N) (x, any amino acid) (Engel et al., 2012). This gene, designated antY (anti-ficY), is transcribed divergently from ficY. As expected, the inclusion of AntY in reactions containing YpParE and FicY led to complete inhibition of the modification, which is similar to the inhibition of Fic-1 activity by AntF (Supplementary Figure S4A) (Lu et al., 2016). Furthermore, the inhibition by AntY is dose-dependent, and the activity was completely inhibited when the molar ratio between FicY and AntY reached 1:3 (Supplementary Figure S4B). Thus, FicY, and AntY constitute a type II toxin and antitoxin module.
Fic Proteins Affect DNA Topology in vitro
In bacteria, DNA gyrase is responsible for the introduction of negative supercoiling into relaxed DNA, and Topo IV catalyzes the relaxation of supercoiled DNA and decatenation of newly replicated DNA (Gellert et al., 1976; Kato et al., 1990). The observation that GyrB and ParE are targeted by Fic proteins prompted us to test how such modification affects their activity by examining their impact on the topological status of plasmid DNA.
DNA gyrase (GyrA and GyrB) from P. fluorescens (PfGyrase) introduced negative supercoiling into relaxed plasmid DNA. However, this activity became undetectable when equal amounts of Fic-1-treated PfGyrase were used. In line with its loss of catalytic activity, treatment with the Fic-1H135A mutant did not affect the activity of PfGyrB (Figure 5A). Thus, AMPylation by Fic-1 abolishes DNA gyrase activity. Consistent with its inability to modify gyrase, pre-incubation of FicY with the DNA gyrase from Y. pseudotuberculosis (YpGyrase) did not affect its activity (Figure 5B). Furthermore, both Fic-1 and FicY had no effect on the relaxation activity of DNA gyrase in the absence of ATP (Supplementary Figure S5).
FIGURE 5
Inclusion of Fic-1 but not Fic-1H135A in reactions containing Topo IV (ParC and ParE) proteins and supercoiled plasmid DNA led to detectable but not complete inhibition of the relaxation activity of the DNA topological enzymes from P. fluorescens (Figure 5C). In contrast, the activity of Y. pseudotuberculosis Topo IV can be completely inhibited by FicY after incubation for a similar duration and such inhibition required a functional Fic domain (Figure 5D).
Inhibition of Topo IV by Fic Proteins Causes Cell Filamentation and Induces the SOS Response
Inactive ParE is unable to relax positive supercoils in DNA, which will impact the segregation of newly replicated chromosomes, leading to the accumulation of DNA at the center of the cell, inhibition of cell growth and eventually the generation of filamentous cells (Bahng et al., 2000). To test whether Fic-mediated AMPylation of ParE affects the biological function of Topo IV, we expressed Fic proteins and their mutants in the E. coli strain BL21(DE3). Strains harboring plasmids expressing tagged fic-1 or fic-2E56G gene formed smaller colonies on LB plates. In contrast, cells expressing other Fic proteins formed colonies with sizes similar to those containing an empty vector (Supplementary Figure S6). Induction of the expression of proteins FicY, Fic-2E56G, PA1366, and Fic-1 by IPTG led to cell growth arrest in liquid cultures. No such inhibition was observed in strains carrying FicYH141A, PA1366H136A, Fic-2H179A, or Fic-1H141A, which grew indistinguishably to the control strain harboring the empty vector (Figure 6A).
FIGURE 6
We also examined the cell morphology by microscopic analysis and found that cells expressing FicY, Fic-2E56G, PA1366, or Fic-1 became filamentous. The typical par phenotype characterized by filamentous cells and un-segregated nucleoids was apparent in strains expressing Fic-2E56G. In contrast, no filamentous cell was found in strains expressing FicYH141A, Fic-2H179A, PA1366H136A, or Fic-1H135A (Figure 6B). Cells from samples expressing active Fic proteins were significantly (p < 0.05) longer than those expressing their inactive mutants (Figure 6C and Supplementary Figure S7). We also examined the induction of the SOS response in these strains and found that the levels of RecA increased in cells expressing Fic-2E56G, Fic-1, PA1366, FicY which is similar to cells treated with the antibiotic ciprofloxacin (0.25 μg/mL). Consistent with other phenotypes, expression of Fic-2, Fic-2H179A, Fic-1H135A, PA1366H136A, or FicYH141A did not induce the SOS response (Figures 6D,E). These results indicate that several Fic proteins target proteins involved in DNA replication and segregation, leading to cell filamentation and the induction of SOS response.
We also examined the effect of Fic-2 and FicY on P. fluorescens and Y. pseudotuberculosis, respectively. Although no typical par phenotype was observed, more cells unable to retain the Hoechst stain (anucleoid cells) were found in samples overexpressing Fic-2. A similar phenotype was found in cells overexpressing PfParEY109A. No such phenotype was observed in cells harboring the vector or overexpressing PfParE (Figure 7A). In contrast, overexpression of FicY in Y. pseudotuberculosis triggered a canonical par phenotype. Shorter cell length and compact nucleoids were observed in cells expressing FicYH141A and ParEY105A, but not in cells expressing YpParE (Figure 7B). To examine whether inhibition of ParE induced the SOS response, we probed the protein levels of RecA and LexA in cells expressing FicY and found that RecA was induced, which was accompanied by a decrease in LexA. Such changes did not occur in cells overexpressing YpParE or YpParEY106A (Figure 7C). We also observed slight elongation of cells expressing FicYH141A, which may be caused by titration of endogenous AntY by this mutant. These results indicate that the modification of YpParE by FicY can lead to the development of a typical par phenotype and the induction of the SOS response.
FIGURE 7
Discussion
DNA gyrase and topoisomerase IV regulate underwound or overwound DNA during chromosome replication, segregation, and transcription, and are targeted by many antibacterial agents as well as toxins encoded by genes on bacterial chromosomes or plasmids. Antibiotics targeting these enzymes include well-characterized quinolones and coumarins such as nalidixic acid, ciprofloxacin, novobiocin and clorobiocin, which function by competing with ATP for the binding site on the B subunit (Mayer and Janin, 2014; Hooper and Jacoby, 2016). Plasmid-born toxins such as ParERK2, CcdBF and microcins inhibit the supercoiling activity of DNA gyrase by either targeting the subunit(s) of gyrase or the DNA-gyrase cleavage complex (Dao-Thi et al., 2005; Pierrat and Maxwell, 2005; Deghorain et al., 2013; Metelev et al., 2013; Bush et al., 2015). A recently identified antibiotics and phytotoxin albicidin from Xanthomonas albilineans interferes with the catalytic DNA cleavage-religation cycle of the GyrA subunit of DNA gyrase and traps it in a conformation that differs from that targeted by quinolones (Cociancich et al., 2015).
Here, we found that Fic-1 from P. fluorescens inhibits DNA replication by targeting both GyrB and ParE at a highly conserved Tyr residue. This property is similar to VbhT, a Fic protein from Bartonalla schoenbuchensis that also AMPylates both GyrB and ParE (Harms et al., 2015). In our assays, we consistently observed that the activity of Fic-1 toward GyrB appears more robust than that toward ParE. In line with the observation that targeting GyrB by Fic-1 abolished its ATPase activity, the supercoiling activity of the gyrase is completely abolished upon AMPylation induced by Fic-1. In contrast, AMPylation of ParE has little effects on the supercoiling relaxation activity.
Differing from Fic-1 from P. fluorescens, FicY of Y. pseudotuberculosis prefers ParE (Figure 3B). AMPylation of ParE by FicY blocked the relaxation ability of Topo IV, leading to the development of a typical par phenotype characterized by cell filamentation and unsegregated nucleoids (Figure 7B). The relationship between FicY and AntY and organization of their genes suggest that these two proteins form a canonical type II toxin-antitoxin system. The ficY and antY genes transcribe convergently, which differs from fic-1 and antF that appears to be controlled by the same promoter (Supplementary Figure S2) (Lu et al., 2016). Apparently, the expression of ficY and antY is controlled by independent promoters, which may allow more specific regulation.
Some Fic proteins such as dFic from Drosophila, HYPE, and EfFIC from Enterococcus faecalis harbor an intramolecular inhibitory motif and their activity is influenced by the oligomeric state of the enzyme and the presence of certain metal ions (Casey et al., 2017; Preissler et al., 2017; Perera et al., 2019; Veyron et al., 2019). Similar to these proteins, Fic-2 harbors an inhibitory motif in its amino terminal portion capable of blocking its AMPylation activity. Mutations that abolished the predicted inhibitory motif allowed detectable modification of ParE by Fic-2 at levels considerably lower than those of Fic-1 or FicY. Interestingly, albeit both Fic-2E56G and Fic-1 AMPylate ParE, these two proteins appear to differently impact cellular processes of E. coli and P. fluorescens. In E. coli, ectopic expression of Fic-1 causes filamentation (Lu et al., 2016), whereas Fic-2E56G induces a typical par phenotype. In P. fluorescens, expression of Fic-2 led to the formation of cells without nucleoids, suggestive of inhibition of DNA separation (Figure 7A). Of note is that the carboxyl-terminal portion of Fic-2 is predicted to contain a helix-turn-helix motif often involved in DNA binding, yet the role of this putative motif in bacterial physiology, if any, awaits further investigation. A recent study found that the AMPylation activity of Fic protein from Clostridium difficile occurs independently of its predicted inhibitory domain (Dedic et al., 2016). Interestingly, self-modification of Sa1560 appeared to occur in reactions containing wild type protein, suggesting that the AMPylation activity of Sa1560 is independent of its inhibitory motif.
Only a fraction of Fic proteins tested in this study AMPylate the DNA gyrase or topoisomerase IV. Those that display undetectable activity against these two enzymes involved in DNA topology may have different cellular targets or enzymatic activities distinct from AMPylators. In our auto-AMPylation reactions, only Fic-1, Fic-2, FicY, and Sa1560 showed auto-AMPylation activity. Introduction of mutations that abolished the predicted intramolecular inhibitory motifs of class II (Fic-2 and Fic-3 from P. fluorescens; PA0547 from P. aeruginosa) and class III (Sp0496 from S. pneumoniae) did not lead to proteins with detectable activity (Supplementary Figure S8). In addition, overexpression of these Fic proteins or their presumably constitutively active mutants in E. coli did not affect cell division (Supplementary Figure S7). Theses Fic proteins may target proteins other than GyrB and ParE, and the lack of auto-AMPylation activity suggests that they have biochemical activities distinct from AMPylators. Alternatively, our experimental conditions may not be suitable for the detection of their activity.
In line with their inhibition of the enzymatic activity of GyrB and ParE, overexpression of the Fic proteins robustly induced the SOS response (Figure 8). Blockage of DNA replication by Fic proteins likely leads to the accumulation of ssDNA, which is the direct effects of physical and chemical assaults mediated by UV radiation or antibiotics such as mitomycin C (Dörr et al., 2009). We propose that one or more yet unidentified cues induce the expression of the Fic genes or tilts the balance between a Fic protein and its inhibitor in a direction that favors Fic activity, leading to temporal inhibition of DNA replication, which gives the affected cells a better chance to survive.
FIGURE 8
AMPylation induced by Fic proteins or other AMPylators is reversible by specific enzymes (Tan and Luo, 2011). Recent interesting studies reveal that the human Fic protein HYPE displays a deAMPylase activity in response to fluctuations in the unfolded protein load (Casey et al., 2017; Preissler et al., 2017; Perera et al., 2019; Veyron et al., 2019). Whether and how the activity of Fic proteins from other organisms is regulated awaits further investigation.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.
Author contributions
C-HL, Z-QL, and L-QZ designed the research and analyzed the data. C-HL, AM, EN, and F-RC performed the research. C-HL, AM, L-QZ, and Z-QL wrote the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the National Natural Science Foundation of China grants (31872020 and 31572045), the National Key Research and Development Program (2017YFD0201106 to L-QZ), the 111 Project B13006 (to Y.-L. Peng; China Agricultural University), Yunnan Provincial Tobacco Monopoly Bureau grants 2018530000241006, 2019530000241007 and 2020530000241013 (to C-HL), and by National Institutes of Health grant R01AI127465 (to Z-QL). C-HL was supported by a scholarship from the China Scholarship Council. Part of this work was performed in W. R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a Department of Energy (DOE) Office of Biological and Environmental Research (BER) national user facility located at Pacific Northwest National Laboratory (PNNL).
Acknowledgments
We thank Dr. Xuming Deng (Jilin University), Dr. David Russell (Cornell University), and Dr. Xihui Shen (Northwestern A&F University) for bacterial genomic DNA or bacterial strains.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2020.02084/full#supplementary-material
References
1
BahngS.MossessovaE.NurseP.MariansK. J. (2000). Mutational analysis of Escherichia coli topoisomerase IV III. Identification of a region of ParE involved in covalent catalysis.J. Biol. Chem.2754112–4117. 10.1074/jbc.275.6.4112
2
BlattnerF. R.PlunkettG. I.BlochC. A.PernaN. T.BurlandV.RileyM.et al (1997). The complete genome sequence of Escherichia coli K-12.Science2771453–1462. 10.1126/science.277.5331.1453
3
BushN.Evans-RobertsK.MaxwellA. (2015). DNA topoisomerases.EcoSal Plus610.1128/ecosalplus.ESP-0010-2014[Epub ahead of print].
4
CaseyA. K.MoehlmanA. T.ZhangJ.ServageK. A.KrämerH.OrthK. (2017). Fic-mediated deAMPylation is not dependent on homodimerization and rescues toxic AMPylation in flies.J. Biol. Chem.29221193–21204. 10.1074/jbc.M117.799296
5
Castro-RoaD.Garcia-PinoA.De GieterS.van NulandN. A. J.LorisR.ZenkinN. (2013). The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu.Nat. Chem. Biol.9811–817. 10.1038/nchembio.1364
6
CociancichS.PesicA.PetrasD.UhlmannS.KretzJ.SchubertV.et al (2015). The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine.Nat. Chem. Biol.11195–197. 10.1038/nchembio.1734
7
CruzJ. W.RothenbacherF. P.MaehigashiT.LaneW. S.DunhamC. M.WoychikN. A. (2014). Doc toxin is a kinase that inactivates elongation factor Tu.J. Biol. Chem.2897788–7798. 10.1074/jbc.M113.544429
8
Dao-ThiM.-H.Van MelderenL.De GenstE.AfifH.ButsL.WynsL.et al (2005). Molecular basis of gyrase poisoning by the addiction toxin CcdB.J. Mol. Biol.3481091–1102. 10.1016/j.jmb.2005.03.049
9
DedicE.AlsarrafH.WelnerD. H.ØstergaardO.KlychnikovO. I.HensbergenP. J.et al (2016). A novel Fic (filamentation induced by cAMP) protein from Clostridium difficile reveals an inhibitory motif-independent adenylylation/AMPylation mechanism.J. Biol. Chem.29113286–13300. 10.1074/jbc.M115.705491
10
DeghorainM.GoedersN.JovéT.Van MelderenL. (2013). “Type II toxin-antitoxin loci: the ccdAB and parDE families,” in Prokaryotic Toxin-Antitoxins, ed.GerdesK. (London: Springer), 45–67. 10.1007/978-3-642-33253-1_4
11
DiepB. A.GillS. R.ChangR. F.PhanT. H.ChenJ. H.DavidsonM. G.et al (2006). Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.Lancet367731–739. 10.1016/S0140-6736(06)68231-7
12
DörrT.LewisK.VulićM. (2009). SOS response induces persistence to fluoroquinolones in Escherichia coli.PLoS Genet.5:e1000760. 10.1371/journal.pgen.1000760
13
EngelP.GoepfertA.StangerF. V.HarmsA.SchmidtA.SchirmerT.et al (2012). Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins.Nature482107–110. 10.1038/nature10729
14
FengF.YangF.RongW.WuX.ZhangJ.ChenS.et al (2012). A Xanthomonas uridine 5’-monophosphate transferase inhibits plant immune kinases.Nature485114–118. 10.1038/nature10962
15
GellertM.MizuuchiK.O’DeaM. H.NashH. A. (1976). DNA gyrase: an enzyme that introduces superhelical turns into DNA.Proc. Natl. Acad. Sci. U.S.A.733872–3876. 10.1073/pnas.73.11.3872
16
GrammelM.LuongP.OrthK.HangH. C. (2011). A chemical reporter for protein AMPylation.J. Am. Chem. Soc.13317103–17105. 10.1021/ja205137d
17
HamH.WooleryA. R.TracyC.StenesenD.KrämerH.OrthK. (2014). Unfolded protein response-regulated Drosophila Fic (dFic) protein reversibly AMPylates BiP chaperone during endoplasmic reticulum homeostasis.J. Biol. Chem.28936059–36069. 10.1074/jbc.M114.612515
18
HarmsA.StangerF. V.ScheuP. D.de JongI. G.GoepfertA.GlatterT.et al (2015). Adenylylation of gyrase and topo IV by FicT toxins disrupts bacterial DNA topology.Cell Rep.121497–1507. 10.1016/j.celrep.2015.07.056
19
HooperD. C.JacobyG. A. (2016). Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance.Cold Spring Harb. Perspect. Med.6:a025320. 10.1101/cshperspect.a025320
20
JohnsonS. L.DaligaultH. E.DavenportK. W.JaissleJ.FreyK. G.LadnerJ. T.et al (2015). Thirty-two complete genome assemblies of nine Yersinia species, including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica.Genome Announc.3:e00148-15. 10.1128/genomeA.00148-15
21
KarimovaG.PidouxJ.UllmannA.LadantD. (1998). A bacterial two-hybrid system based on a reconstituted signal transduction pathway.Proc. Natl. Acad. Sci. U.S.A.955752–5756. 10.1073/pnas.95.10.5752
22
KatoJ.-I.NishimuraY.ImamuraR.NikiH.HiragaS.SuzukiH. (1990). New topoisomerase essential for chromosome segregation in E. coli.Cell63393–404. 10.1016/0092-8674(90)90172-b
23
KinchL. N.YarbroughM. L.OrthK.GrishinN. V. (2009). Fido, a novel AMPylation domain common to Fic, Doc, and AvrB.PLoS One4:e5818. 10.1371/journal.pone.0005818
24
LanieJ. A.NgW.-L.KazmierczakK. M.AndrzejewskiT. M.DavidsenT. M.WayneK. J.et al (2007). Genome sequence of Avery’s virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6.J. Bacteriol.18938–51. 10.1128/jb.01148-06
25
LiuY.TanS.HuangL.AbramovitchR. B.RohdeK. H.ZimmermanM. D.et al (2016). Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.J. Exp. Med.213809–825. 10.1084/jem.20151248
26
LuC.NakayasuE. S.ZhangL.-Q.LuoZ.-Q. (2016). Identification of Fic-1 as an enzyme that inhibits bacterial DNA replication by AMPylating GyrB, promoting filament formation.Sci. Signal.9:ra11. 10.1126/scisignal.aad0446
27
MayerC.JaninY. L. (2014). Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.Chem. Rev.1142313–2342. 10.1021/cr4003984
28
MetelevM.SerebryakovaM.GhilarovD.ZhaoY.SeverinovK. (2013). Structure of microcin B-like compounds produced by Pseudomonas syringae and species specificity of their antibacterial action.J. Bacteriol.1954129–4137. 10.1128/jb.00665-13
29
MillerJ. H. (1972). Experiments in Molecular Genetics.New York, NY: Cold Spring Harbor Laboratory Press.
30
MoehlmanA. T.CaseyA. K.ServageK.OrthK.KrämerH. (2018). Adaptation to constant light requires Fic-mediated AMPylation of BiP to protect against reversible photoreceptor degeneration.eLife7:e38752. 10.7554/eLife.38752
31
MukherjeeS.LiuX.ArasakiK.McDonoughJ.GalánJ. E.RoyC. R. (2011). Modulation of Rab GTPase function by a protein phosphocholine transferase.Nature477103–106. 10.1038/nature10335
32
PereraL. A.RatoC.YanY.NeidhardtL.McLaughlinS. H.ReadR. J.et al (2019). An oligomeric state-dependent switch in the ER enzyme FICD regulates AMPylation and deAMPylation of BiP.EMBO J.38:e102177. 10.15252/embj.2019102177
33
PierratO. A.MaxwellA. (2005). Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA Gyrase.Biochemistry444204–4215. 10.1021/bi0478751
34
PreisslerS.RatoC.PereraL.SaudekV.RonD. (2017). FICD acts bi-functionally to AMPylate and de-AMPylate the endoplasmic reticulum chaperone BiP.Nat. Struct. Mol. Biol.2423–29. 10.1101/071332
35
RahmanM.HamH.LiuX.SugiuraY.OrthK.KrämerH. (2012). Visual neurotransmission in Drosophila requires expression of Fic in glial capitate projections.Nat. Neurosci.15871–875. 10.1038/nn.3102
36
SanyalA.ChenA. J.NakayasuE. S.LazarC. S.ZbornikE. A.WorbyC. A.et al (2015). A novel link between Fic (Filamentation induced by cAMP)-mediated adenylylation/AMPylation and the unfolded protein response.J. Biol. Chem.2908482–8499. 10.1074/jbc.M114.618348
37
SiamerS.DehioC. (2015). New insights into the role of Bartonella effector proteins in pathogenesis.Curr. Opin. Microbiol.2380–85. 10.1016/j.mib.2014.11.007
38
SprengerH.KienesbergerS.PertschyB.PöltlL.KonradB.BhutadaP.et al (2017). Fic proteins of Campylobacter fetus subsp. venerealis form a network of functional toxin–antitoxin systems.Front. Microbiol.8:1965. 10.3389/fmicb.2017.01965
39
StangerF. V.BurmannB. M.HarmsA.AragãoH.MazurA.SharpeT.et al (2016). Intrinsic regulation of FIC-domain AMP-transferases by oligomerization and automodification.Proc. Natl. Acad. Sci. U.S.A.113E529–E537. 10.1073/pnas.1516930113
40
StoverC. K.PhamX. Q.ErwinA. L.MizoguchiS. D.WarrenerP.HickeyM. J.et al (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.Nature406959–964. 10.1038/35023079
41
TanY.ArnoldR. J.LuoZ.-Q. (2011). Legionella pneumophila regulates the small GTPase Rab1 activity by reversible phosphorylcholination.Proc. Natl. Acad. Sci. U.S.A.10821212–21217. 10.1073/pnas.1114023109
42
TanY.LuoZ.-Q. (2011). Legionella pneumophila SidD is a deAMPylase that modifies Rab1.Nature475506–509. 10.1038/nature10307
43
TruttmannM. C.PloeghH. L. (2017). rAMPing up stress signaling: protein AMPylation in metazoans.Trends Cell Biol.27608–620. 10.1016/j.tcb.2017.03.004
44
VeyronS.OlivaG.RolandoM.BuchrieserC.PeyrocheG.CherfilsJ. (2019). A Ca2+-regulated deAMPylation switch in human and bacterial FIC proteins.Nat. Commun.10:1142. 10.1038/s41467-019-09023-1
45
VeyronS.PeyrocheG.CherfilsJ. (2018). FIC proteins: from bacteria to humans and back again.Pathog. Dis.76:fty012. 10.1093/femspd/fty012
46
WangT.SiM.SongY.ZhuW.GaoF.WangY.et al (2015). Type VI secretion system transports Zn2+ to combat multiple stresses and host immunity.PLoS Pathog.11:e1005020. 10.1371/journal.ppat.1005020
47
WeiH.-L.ZhangL.-Q. (2006). Quorum-sensing system influences root colonization and biological control ability in Pseudomonas fluorescens 2P24.Antonie van Leeuwenhoek89267–280. 10.1007/s10482-005-9028-8
48
WorbyC. A.MattooS.KrugerR. P.CorbeilL. B.KollerA.MendezJ. C.et al (2009). The fic domain: regulation of cell signaling by adenylylation.Mol. Cell3493–103. 10.1016/j.molcel.2009.03.008
49
WuX.-G.DuanH.-M.TianT.YaoN.ZhouH.-Y.ZhangL.-Q. (2010). Effect of the hfq gene on 2, 4-diacetylphloroglucinol production and the PcoI/PcoR quorum-sensing system in Pseudomonas fluorescens 2P24.FEMS Microbiol. Lett.30916–24. 10.1111/j.1574-6968.2010.02009.x
50
YarbroughM. L.LiY.KinchL. N.GrishinN. V.BallH. L.OrthK. (2009). AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling.Science323269–272. 10.1126/science.1166382
51
ZhangW.ZhaoZ.ZhangB.WuX.-G.RenZ.-G.ZhangL.-Q. (2014). Posttranscriptional regulation of 2, 4-diacetylphloroglucinol production by GidA and TrmE in Pseudomonas fluorescens 2P24.Appl. Environ. Microbiol.803972–3981. 10.1128/AEM.00455-14
Summary
Keywords
post-translational modification, toxin-antitoxin, AMPylation, filamentation induced by cAMP, DNA gyrase, topoisomerase IV, cell filamentation, DNA replication
Citation
Lu C-H, McCloskey A, Chen F-R, Nakayasu ES, Zhang L-Q and Luo Z-Q (2020) Fic Proteins Inhibit the Activity of Topoisomerase IV by AMPylation in Diverse Bacteria. Front. Microbiol. 11:2084. doi: 10.3389/fmicb.2020.02084
Received
29 March 2020
Accepted
07 August 2020
Published
26 August 2020
Volume
11 - 2020
Edited by
Hui Wu, East China University of Science and Technology, China
Reviewed by
Peter Graumann, University of Marburg, Germany; Kim Orth, University of Texas Southwestern Medical Center, United States
Updates
Copyright
© 2020 Lu, McCloskey, Chen, Nakayasu, Zhang and Luo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Li-Qun Zhang, zhanglq@cau.edu.cnZhao-Qing Luo, luoz@purdue.edu
This article was submitted to Microbial Physiology and Metabolism, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.